BladderCancer.org.au co-founder and board member Professor Nathan Lawrentschuk has been awarded the USANZ Medal. The medal is an honour bestowed upon a USANZ member who has given exceptional service & leadership over a considerable number of years. Congratulations Nathan!
Bladder Cancer Australia
My Health Record
My Health Record – why it matters, especially for bladder cancer patients The uptake on the My Health Record program, as part of Medicare, is strong with patients, but under-utilized by doctors, nurses and hospitals. As a Bladder Cancer survivor, I am keen to have My Health Record up to date, so if I had […]
OUR 2026 USANZ BLADDER CANCER HIGHLIGHTS
USANZ 2026, in its 30th year, offers fresh and exciting opportunities for continuing professional development offered by national and international experts. Highlights of the program that pertain to Bladder Cancer, or selected related issues, or are presented or chaired by our co-founder and co-chair, Professor Nathan Lawrentschuk and former board member Shane Qin, include:Saturday, 28th […]
Australian Celebrities Speak Out About Cancer
We often hear of international celebrities, such as the recent announcement by Deion Sanders, 57, two-time US NFL hall-of-famer champion, put the spotlight on their battles with cancer, but a number of Australian celebrities have also drawn attention to their own or their friends’ cancer experience. Using their celebrity status to highlight the effects of […]
New bladder cancer treatments and how they work
Non-muscle-invasive bladder cancer (NMIBC) is a form of bladder cancer that remains within the bladder lining and has not invaded deeper tissues. Standard treatments, such as intravesical (“in-bladder”) Bacillus Calmette-Guérin (BCG) (a live attenuated bacteria) or chemotherapy, are usually effective. However, these treatments may fail to control the disease for some patients.
An update from Shane Quin on immunotherapy treatments for bladder cancer.
Immunotherapy has been an area of significant research in recent years. A plethora of clinical trials have been undertaken investigating their use in the treatment of metastatic bladder cancer. Immune checkpoint inhibitors have emerged as new targeted agents (e.g. pembrolizumab, avelumab, nivolumab) that are used in certain settings.
Australian Cancer Plan
The Federal Government recently (November 2023) launched a 10-year plan to improve the outcomes and lived experience of all people with cancer in Australia. The following six strategic objectives underpin the Plan.
Artificial Intelligence In Bladder Cancer
Artificial intelligence (AI) has been in the spotlight in recent years and is strongly believed to be able to impact all areas of healthcare in the future. Bladder cancer is one area where extensive AI research is being undertaken in diagnosis, recurrence and survival.
USANZ22 EKO Guitar Winner
The Bladder Cancer Australia Charity Foundation guitar prize is fast becoming a popular convention must do at at USANZ. Delegates visiting our convention booth for our latest bladder cancer patient literature and other resources also sign up for a chance to win our guitar prize. The lucky winner this year is Nick Davies from Tasmania! […]
BladderCancer.org.au at USANZ22
The Urological Society of Australia and New Zealand 2022 Conference We are distributing our Bladder Cancer Patient Guidebook and other patient resources at USANZ22 Our booth also has a draw going for an EKO EVO III D EQ guitar valued at $899.00 Note that there are costs involved in attending a conference like this and […]
Small Cell Carcinoma of the Bladder
Last year on October 26th, I lost my dad to small cell carcinoma of the bladder which in case you didn’t know is very rare.
Victorian Urological Nurses Society (VUNS) Bladder Cancer Group – An Overview
By Marc DioceraGroup Coordinator, VUNS Bladder Cancer GroupGenitourinary Nurse Consultant, Peter MacCallum Cancer Centre The Victorian Urological Nurses Society (VUNS) Bladder Cancer Specialist Interest Group (SIG) is a sub-speciality group of advanced practice nurses caring for patients with bladder cancer. The group was originally formed by Victorian urology nurses in 2013 to address the issues […]